Cree encephalitis is allelic with Aicardi-Goutieres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism

被引:92
|
作者
Crow, YJ
Black, DN
Ali, M
Bond, J
Jackson, AP
Lefson, M
Michaud, J
Roberts, E
Stephenson, JBP
Woods, CG
Lebon, P
机构
[1] St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, St James Univ Hosp, Mol Med Unit, Leeds, W Yorkshire, England
[3] Montreal Neurol Inst, Dept Neurogenet, Montreal, PQ, Canada
[4] Chisasibi Hosp, Dept Family Hlth, Quebec City, PQ, Canada
[5] Hop St Justine, Div Med Genet, Montreal, PQ, Canada
[6] Yorkhill Hosp, Dept Paediat Neurol, Glasgow, Lanark, Scotland
[7] Hop St Vincent de Paul, Serv Virol, F-75674 Paris, France
[8] Univ Paris 05, EA 3622, Paris, France
关键词
D O I
10.1136/jmg.40.3.183
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aicardi-Goutieres syndrome (AGS) is an early onset, progressive encephalopathy characterised by calcification of the basal ganglia, white matter abnormalities, and a chronic cerebrospinal fluid (CSF) lymphocytosis. Cree encephalitis shows phenotypic overlap with AGS although the conditions have been considered distinct because of immunological abnormalities observed in Cree encephalitis. We report that levels of interferon alpha (IFN-alpha), a marker of AGS, are raised in Cree encephalitis. Moreover, linkage analysis indicates that the disorders are allelic and refines the AGS1 locus to a 3.47 cM critical interval. Our data show that a CSF lymphocytosis is not necessary for the diagnosis of AGS and strongly suggest that AGS and pseudo-TORCH syndrome are the same disorder. Recognition of immunological dysfunction as part of the AGS phenotype provides further evidence of a primary pathogenic role for abnormal IFN-alpha production in AGS.
引用
收藏
页码:183 / 187
页数:5
相关论文
共 25 条
  • [21] Rare variants in the Aicardi-Goutieres syndrome genes ADAR and RNASEH2B and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis
    Brand, F.
    Beyer, U.
    Martens, H.
    Weder, J.
    Christians, A.
    Elyan, N.
    Hentschel, B.
    Westphal, M.
    Schackert, G.
    Pietsch, T.
    Hong, B.
    Krauss, J. K.
    Samii, A.
    Raab, P.
    Das, A.
    Dumitru, C. A.
    Sandalcioglu, I. E.
    Hakenberg, O. W.
    Erbersdobler, A.
    Lehmann, U.
    Reifenberger, G.
    Weller, M.
    Reijns, M. A. M.
    Preller, M.
    Wiese, B.
    Hartmann, C.
    Weber, R. G.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 829 - 830
  • [22] A SAMHD1 mutation associated with Aicardi-Goutieres syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans
    White, Tommy E.
    Brandariz-Nunez, Alberto
    Martinez-Lopez, Alicia
    Knowlton, Caitlin
    Lenzi, Gina
    Kim, Baek
    Ivanov, Dmitri
    Diaz-Griffero, Felipe
    HUMAN MUTATION, 2017, 38 (06) : 658 - 668
  • [23] Cytokine Profile Comparison of Monogenic and Complex Conditions with Interferon-Regulated Gene Signatures in Chronic Atypical Neutrophilic Dermatosis with Lipodsytrophy and Elevated Temperature (CANDLE), SAVI, Aicardi-Goutieres Syndrome, JDM, and SLE
    Kim, Hanna
    Liu, Yin
    de Jesus, Adriana Almeida
    Wesley, Robert
    Huang, Yan
    Sanchez, Gina A. Montealegre
    Chapelle, Dawn C.
    Tsai, Wanxia L.
    Gadina, Massimo G.
    Miller, Frederick W.
    Hasni, Sarfaraz
    Vanderver, Adeline
    Rider, Lisa G.
    Goldbach-Mansky, Raphaela
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [24] Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi-Goutieres syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1)
    Fuchs, Nina V.
    Schieck, Maximilian
    Neuenkirch, Michaela
    Tondera, Christiane
    Schmitz, Heike
    Wendeburg, Lena
    Steinemann, Doris
    Elpers, Christiane
    Rutsch, Frank
    Koenig, Renate
    STEM CELL RESEARCH, 2020, 43
  • [25] Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
    Rice, Gillian I.
    Forte, Gabriella M. A.
    Szynkiewicz, Marcin
    Chase, Diana S.
    Aeby, Alec
    Abdel-Hamid, Mohamed S.
    Ackroyd, Sam
    Allcock, Rebecca
    Bailey, Kathryn M.
    Balottin, Umberto
    Barnerias, Christine
    Bernard, Genevieve
    Bodemer, Christine
    Botella, Maria P.
    Cereda, Cristina
    Chandler, Kate E.
    Dabydeen, Lyvia
    Dale, Russell C.
    De Laet, Corinne
    De Goede, Christian G. E. L.
    del Toro, Mireia
    Effat, Laila
    Nunez Enamorado, Noemi
    Fazzi, Elisa
    Gener, Blanca
    Haldre, Madli
    Lin, Jean-Pierre S-M
    Livingston, John H.
    Lourenco, Charles Marques
    Marques, Wilson, Jr.
    Oades, Patrick
    Peterson, Paert
    Rasmussen, Magnhild
    Roubertie, Agathe
    Schmidt, Johanna Loewenstein
    Shalev, Stavit A.
    Simon, Rogelio
    Spiegel, Ronen
    Swoboda, Kathryn J.
    Temtamy, Samia A.
    Vassallo, Grace
    Vilain, Catheline N.
    Vogt, Julie
    Wermenbol, Vanessa
    Whitehouse, William P.
    Soler, Doriette
    Olivieri, Ivana
    Orcesi, Simona
    Aglan, Mona S.
    Zaki, Maha S.
    LANCET NEUROLOGY, 2013, 12 (12): : 1159 - 1169